第一作者:
Shady,Adnan-Awad
第一单位:
Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland.
作者:
医学主题词
抗药性, 肿瘤(Drug Resistance, Neoplasm);融合蛋白质类, bcr-abl(Fusion Proteins, bcr-abl);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);突变(Mutation);癌基因(Oncogenes);蛋白激酶抑制剂(Protein Kinase Inhibitors)
DOI
10.1080/10428194.2021.1894652
PMID
33944660
发布时间
2021-10-21
- 浏览4
Leukemia & lymphoma
2064-2078页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



